BROWSE BY CATEGORY:

  • All
  • BrillianSe
  • Incite
  • KA Imaging
  • press-release
  • Reveal
  • Reveal (NDT)
  • Reveal (vet)
  • Sight

Indonesian market will be able to access KA Imaging’s Reveal 35C dual-energy solution  Waterloo, Ont. (Oct 19, 2021) - KA Imaging has entered into a distribution agreement with PT. Intimedika Puspa Indah for distribution of its innovative dual–energy imaging solution Reveal™ 35C in the Indonesian market.   "We’re happy to have initiated this partnership, as dual-energy subtraction can be very helpful in advance studies for...

Dual energy has been around for more than 30 years, but due to weaknesses in older technologies, it has never taken off. Reveal 35C overcomes the limitations of traditional approaches by providing three separate images without motion artifacts from a single shot.https://www.youtube.com/watch?v=dypvAjAfa_U...

Dr. Karim S. Karim, CTO of KA Imaging, and Jay Potipcoe, Applications Specialist, presented a free 60-minute live webinar on Wednesday, October 27 about Saving Costs and Optimizing ICU use with dual energy subtraction. Through the presentation, attendees learned about dual-energy subtraction X-ray imaging, had...

World Lung Day (WLD) on September 25 is a day of awareness and action for lung health, a chance for all of us to come together and promote improved lung health around the world. Hundreds of millions of people around the world are affected by...

NEW Competition to Find the Next Enterprise Startup Unicorn  September 20, 2021— KA Imaging announced it was named as the second-place winner of The Pitch, a new competition for enterprise startups hosted by Constellation Research. The industry wide two-day event brought together startup founders, enterprise technology decision makers,...

One emerging application for dual-energy X-ray subtraction is the opportunistic detection of coronary calcifications. Coronary artery calcifications (CAC), or the presence of calcium buildups in arteries that supply blood to the heart, is common in patients with coronary heart disease (CHD)3.   A 2021 update by the American Heart Association maintains that CHD is the leading cause of death attributable to cardiovascular disease (CVD) in the US. CVD accounted for approximately 18.6 million...

KA Imaging has been selected to pitch in the Innovator’s Pitch Challenge at Digital RESI September 13-15th. The Redefining Early-Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. In the Challenge, KA Imaging’s CEO Amol Karnick will pitch directly to...

Showcasing Emerging Technologies for Low-Resource Settings Waterloo, Ont. (September 07, 2021) KA Imaging’s Reveal™ 35C has been included in the World Health Organization’s (WHO) compendium of innovative health technologies for low-resource settings, launched August 31, 2021. This compilation features emerging technologies assessed and found to potentially improve health...

Sign up for email updates


KA Imaging is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow KA Imaging to store and process the personal information submitted above to provide you the content requested.

Sign up for email updates